Tag Archives: BTKi

Merck’s Evobrutinib Shows Long-Term Efficacy and Improved Quality of Life in Multiple Sclerosis Patients, Revealing Potential RMS Treatment Advancements

Posted on 12, October 2023 by

(IN BRIEF) Merck has presented new data on evobrutinib, an investigational BTK inhibitor, at the 9th Joint ECTRIMS-ACTRIMS congress. The data from an ongoing Phase II open-label extension study of evobrutinib in patients with relapsing multiple sclerosis (RMS) show sustained … Read the full press release →

Posted in Business, Education, Germany, Healthcare, Industrial, Management, News, Pharma & Biotech, Science

Tagged , , , , , ,